ENSOMA, INC.

Profile

Company Names

ENSOMA, INC.

Addresses

451 D STREET, SUITE 600, BOSTON, MA 02210

451 D STREET, SUITE 600, BOSTON, MA 02210

75 KNEELAND STREET, 14TH FLOOR, BOSTON, MA 02111

Phone Numbers

617-272-2400
617-766-3917

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$169,550,377.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-12-23 
$129,000,467.00 
$129,000,467.00 
$0.00 
Equity 
1
2021-02-05 
$40,549,910.00 
$70,549,902.00 
$29,999,992.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
CHIN 
DIRECTOR
OPTIKIRA, LLC   |  ITERUM THERAPEUTICS LTD   |  HARPOON THERAPEUTICS, INC.   |  AURA BIOSCIENCES, INC.   |  VELOSBIO INC.   |  IMARA INC.   |  ITERUM THERAPEUTICS BERMUDA LTD   |  ITERUM THERAPEUTICS PLC   |  ITERUM THERAPEUTICS US LTD   |  ITERUM THERAPEUTICS US HOLDING LTD   |  ITERUM THERAPEUTICS INTERNATIONAL LTD   |  SORRISO PHARMACEUTICALS, INC.   |  ENSOMA, INC.   |  AVENZOAR PHARMACEUTICALS, INC.
KOUKI 
 
HARASAKI 
DIRECTOR
ARTIFICIAL, INC.   |  KARLSGATE INC.   |  SURGE THERAPEUTICS, INC.   |  ENSOMA, INC.   |  RECODE THERAPEUTICS, INC.   |  BIOLUMINESCENCE VENTURES FUND I, L.P.   |  BIOLUMINESCENCE VENTURES FUND II, L.P.
STEPHEN 
 
KNIGHT 
DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  US GENOMICS INC   |  IORA HEALTH, INC.   |  BLUEPRINT MEDICINES CORP   |  PROTEOSTASIS THERAPEUTICS, INC.   |  SEMMA THERAPEUTICS, INC.   |  BEAM THERAPEUTICS INC.   |  SANA BIOTECHNOLOGY, INC.   |  ENSOMA, INC.   |  QUANTUM CIRCUITS, INC.   |  QUARRY GLUE HOLDING CO LLC
EMILE 
 
NUWAYSIR 
EXECUTIVE OFFICER, DIRECTOR
CELLULAR DYNAMICS INTERNATIONAL, INC.   |  INVENRA INC.   |  ENSOMA, INC.
KUSH 
 
PARMAR 
EXECUTIVE OFFICER, DIRECTOR
ARVINAS, INC.   |  SCPHARMACEUTICALS INC.   |  AUDENTES THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  HOMOLOGY MEDICINES, INC.   |  5AM VENTURES V, L.P.   |  CYCLOPORTERS, INC.   |  AKOUOS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  RALLYBIO HOLDINGS, LLC   |  VOR BIOPHARMA INC.   |  ENSOMA, INC.
KUSH 
M 
PARMAR 
DIRECTOR
ENSOMA, INC.
ALBERT 
 
SEYMOUR 
DIRECTOR
HOMOLOGY MEDICINES, INC.   |  ENSOMA, INC.
NIHAL 
 
SINHA 
DIRECTOR
CHARM THERAPEUTICS INC.   |  ENSOMA, INC.   |  ANTLIA BIOSCIENCE, INC.
PAULA 
 
SOTEROPOULOS 
DIRECTOR
AKCEA THERAPEUTICS, INC.   |  ENSOMA, INC.   |  DIANTHUS THERAPEUTICS, INC.   |  RALLYBIO CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-23 
2023-01-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-23 
2021-02-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#